Speech by the President of the Republic on the occasion of the Global Forum for Innovation and Vaccine Sovereignty.

France Emmanuel Macron · President of France

20 June 2024 · Global Forum for Innovation and Vaccine Sovereignty

Context
Macron addressed the Global Forum for Innovation and Vaccine Sovereignty on June 20, 2024, speaking on Africa-Europe health partnerships and vaccine production equity.
Main themes
Vaccine sovereignty, global health equity, Africa-Europe health partnership, pandemic preparedness, vaccine production capacity in Africa, international solidarity, COVAX initiative, GAVI vaccine alliance, geopolitics of health, France's global health commitments
Duration
~18 min
59th percentile
Words
2,108
59th percentile
Sentences
91
58th percentile
Readability
43
42nd percentile
Grade
12.9
55th percentile
Syntax
3.18
71st percentile
Vocabulary
2.27
66th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 41%41%
  • Ceremonial 23%23%
  • Economic 17%16%
  • Geopolitical 12%12%
  • Institutional 4%4%
  • Technological 2%2%
  • Environmental 0%0%
  • Not in focus 1%

91 sentences in 23 paragraphs

Mr. Presidents of the Republic of Botswana, Ghana, Rwanda, and Senegal.

Mr. President of the African Union Commission, dear Moussa FAKI,

Mr. President BARROSO,

Ladies and gentlemen, leaders of international organizations,

Madam Commissioner,

Ladies and gentlemen, ministers and ambassadors,

Ladies and gentlemen, leaders of pharmaceutical companies, research laboratories, and agents of CDC Africa,

Ladies and gentlemen, representatives of civil society committed to global health,

Dear friends,

I am very happy and very proud of the collective path we have embarked on together in recent years to make health an international priority. Because, first and foremost, it is a vital and collective issue. Protecting others is protecting ourselves, and it is a work of conviction, which we have often done towards the wealthiest countries. It is a true partnership in the truest sense of the word; it is not aid, because if we do not protect the continents affected by the beginnings of a pandemic, the whole world is affected. Because health is a fundamental right and it is an issue of equity and progress, an issue of equality between women and men as well. Health is an issue of sovereignty, at the heart of this partnership, as you just mentioned, between Africa and Europe, which we reaffirmed at the last summit between the African Union and the European Union. Global health has become geopolitical, and cooperation in health is a testament to mutual trust.

This fight for global health is demanding, and I want to say here that France takes it on and is proud of it. Proud that France's contribution to international solidarity has increased by 50% in 7 years with a strong focus on health. Proud to preserve a tool like the Solidarity Fund for Development and the symbolic link between levies on the flows of globalization, such as airline tickets and financial transactions, and the financing of international solidarity. I want to say here that this link will be preserved against all odds. And we can be proud together of the path accomplished with the example of the GAVI vaccine alliance, 1 billion children vaccinated, with this work done in synergy between GAVI, Unitaid, WHO, and all the organizations that contribute to this effort.

When some are tempted by withdrawal, when some consider that, after all, helping Africa or other continents on this issue would be superfluous and a possible source of savings, I reiterate strongly that our conviction is, on the contrary, that this balanced partnership is essential for the African continent and for understanding what the order of the contemporary world is. So, all of this has evolved a lot in recent years, and I remember with you who are here, present today, the period of Covid. From the very first weeks, I was by your side. You had invited me to an African Union office. President Kagame was there. I believe President Nana AKUFO-ADDO was also there, of course, alongside Moussa FAKI, President RAMAPHOSA, and a few others. We were at the beginning of this epidemic that affects us all.

That is how we began to invent this initiative, COVAX, which was later carried by the G20. But it truly belongs to the African Union and to this dialogue we have had with one another. During the pandemic, we established solidarity mechanisms that did not exist. Transfer of doses, initiatives to obtain tests, to deploy vaccines as soon as they became available. Nevertheless, we saw the limits of this solidarity. We all saw them, and in a very simple way, it is that when the wealthiest countries were affected, they prioritized their populations over this solidarity. And even if we had set up these mechanisms, this additional funding. And had we not done so, the situation would have been terrible. We saw certain limits. First, when we had disinvested for so many years in primary health systems in many countries, it was too late to go vaccinate. Then, we saw the other limit, which is that when it became difficult and doses were lacking, the producing countries first kept the initial components for themselves. Europe experienced this, because we were dependent on certain others. And then, wherever we were, we kept our doses before distributing them.

The African continent, which represented 20% of the needs and produces only 2% of vaccine doses in the world, saw the glaring injustice and said: no, we are willing to accept your solidarity for a time, but the heart of the priority is that we can produce. And we began, in the months that followed, as we remember, to develop production capacities relying on the Pasteur Institute in Dakar, developing production capacities that did not exist in Kigali or also going to South Africa, developing new capacities through partnerships. We began this work, realizing that COVAX was not enough, that it was not just about buying, but about producing. And this quest is of singular importance, as I said. Africa produces only 2% of the vaccines it uses, and the goal we have set for ourselves is to be able to produce, by 2040, 60% of these vaccines. France and Europe have supported this ambition since 2021, to the tune of 1.3 billion euros, and it needs to be accelerated. And you just mentioned it, President BARROSO, it is the very heart of this initiative that we are launching today.

A joint commitment of the Vaccine Alliance and the African Union, and it is this spirit of production by the African Union and all the member countries that is the accelerator of vaccine production in Africa and on African soil. France has chosen to reallocate 100 million dollars to this mechanism, and the European team — Madam Commissioner, thank you for your presence — ensures three-quarters of this funding of 1.2 billion dollars alongside our partners, whom I also want to thank, who have committed: the United States, Canada, the United Kingdom, Norway, Japan, and the Gates Foundation.

This is a global movement of which AVMA, this vaccine production accelerator in Africa, will be an essential building block to build this true African vaccine market. This movement is African, and we are happy to support it, to celebrate its first steps, but its strength is that it is thought, designed, and desired by Africans. This is a movement that France supports with more than 300 million euros invested since 2020 on 4 axes. And I want to recall them here because it is a whole solidarity effort. First, production capacities, particularly by supporting the African laboratories Biovac and Aspen, which I was able to visit in the summer of 2021, and the Pasteur Institute in Dakar. Then, it is research and development capacities, notably through this very ambitious initiative carried with WHO, and thanks to Dr. Tedros, and the Medicines Patent Pool, dear Charles GORE, of the hub for the transfer of messenger RNA technology in South Africa, which radiates in 15 countries across the continent, with an important role for Rwanda as well. Thirdly, it is regulatory capacities, and I commend the major progress in Rwanda, Senegal, and the future African Medicines Agency that you just mentioned, President FAKI. And finally, it is the training of professionals in the health product chain with a key role for the WHO Academy. I am also proud to announce that France is joining the International Vaccine Institute, which would find its place within this WHO Academy in Lyon.

To move forward, we will also need the private sector, and I want to commend the commitment of several companies, whether it is EuBiologics in Korea or Sanofi, who will detail their announcements today. This is a very strong signal of the ambition carried by AVMA. This investment in global health is a relentless effort. If we have partially caught up on the routine vaccination delays caused by the pandemic, there is still much work to be done to achieve our equitable access goals by 2030, and we know this. That is why we are launching today in Paris, in parallel, the resource mobilization campaign for GAVI for 2026 to 2030. True to France's historical commitment, I call on all of you here to support this alliance, which is a beautiful demonstration, as you recalled, President BARROSO, of the effectiveness of multilateralism.

France will maintain its support for GAVI for the 2026-2030 cycle, at least at the level of its previous commitment, in order to concretely implement our priorities. To do this, we will need to continue to strengthen our collective action framework, that of GAVI, but also of all other global health initiatives: the Global Fund, UNITAID present here, WHO, of course, in its normative and coordinating role. I believe that all these agencies around the World Health Organization play an essential role, and they must cooperate now, as they have for so many years, but further strengthened, with both, obviously, the normative and coordinating action of WHO, but the national strategies carried and endorsed by the countries. This is the very meaning of the Paris Pact for People and the Planet (4P) that we launched last July, which has also helped mobilize more funding for national health strategies. The presence of several African leaders and several ministers from the continent is essential for this issue. The condition for success is that this international work is based on national strategies carried by the countries, which is consistent with this ownership that you just mentioned, but which is also one of the lessons we have learned from the pandemic. If there is not a strong national strategy carried by the country, and President AKUFO-ADDO knows how much, who defended this idea throughout the crisis, international initiatives, the billions we commit are not effective, because they are only effective if there is a strong national strategy, a consolidated primary health system. This is the very meaning of the action and work that we have greatly strengthened in recent years with AFD, which has provided a lot of funding for the primary health systems of different countries and for our willingness to support these national strategies to strengthen these primary health systems.

I would like to conclude my remarks with a word on the global cholera outbreak, which is, I would say, the most glaring and cruel illustration of the necessity of the effort we are undertaking. Indeed, cholera is currently hitting half of Africa hard. For the past few weeks, the territory of Mayotte has also been affected. And in the face of this urgency, France is proud to have been the first country to respond to the call of WHO. I invite all of you here to heed the call of the World Health Organization. In the face of this type of crisis, our initiative to multiply local production capacities makes perfect sense, as it allows us to strengthen this sovereignty, but also a rapid response. An effective and inexpensive vaccine exists against cholera. However, we are currently facing a global shortage, as there is only one producer who is very far from the African continent.

Today, thanks to the efforts of our partners, notably GAVI, I am happy to announce that a cholera vaccine production chain will be deployed in Africa by our partner Biovac. The tool we are launching today, AVMA, will ultimately support these investments as a priority, which is a very concrete illustration of the relevance of your initiative. As a first concrete demonstration of support, France will allocate 10 million euros to accelerate the production of this cholera vaccine in South Africa. So, if you share this ambition to send cholera back to the past by supporting these emergency actions, investments in local production, and long-term prevention, I invite all of you present here to join this initiative against cholera alongside the 12 countries and organizations present this morning in this room.

I will not take more time, but I want to thank you for your daily commitment, for the commitment of the organizations and alliances I have mentioned, their presidents and directors general. Thank the WHO for its work and say how essential the work of the African Union and the leaders present here is. There are so many priorities on the African continent: security, poverty, food, that I know how great the temptation would be to leave it to others to carry the issue of health. But it is through your constancy and your will, precisely, to strengthen African sovereignty that these initiatives can advance.

I am very proud and happy that France, by welcoming you today, but above all by continuing to engage alongside you, can carry this message.

Thank you all.